Rani Therapeutics

Rani Therapeutics(RANI)

SAN JOSE, CA
Biotechnology3 H-1B visas (FY2023)

Focus: Orally delivered Biologics

Rani Therapeutics is a life sciences company focused on Orally delivered Biologics.

Metabolic Diseases
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

N/A
Clinical Trials (1)
NCT04911296Pill Swallow Study
N/A
RT-114 is the RaniPill capsule with PG-102 for the treatment of obesity
Obesity
Phase 1
Clinical Trials (1)
NCT06891287An Early Phase Study of RT-114
Phase 1
Phase 1
Clinical Trials (1)
NCT05890118Study Evaluating PK of Ustekinumab Administered Orally Via RaniPill™ Capsule
Phase 1
Phase 1
Clinical Trials (1)
NCT05164614Study Evaluating PK of PTH Administered Orally Via RaniPill™ Capsule
Phase 1
RaniPill capsule containing octreotide
Healthy Volunteers
Phase 1
Clinical Trials (1)
NCT03798912A First-in-Human Study of the RaniPill, an Oral Drug Delivery Platform
Phase 1

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 5 clinical trials
H-1B (2023): 3 approvals
SEC Filings: 2 available

Financials (FY2024)

Revenue
$0
R&D Spend
$40M8%
Net Income
-$34M
Cash
$6M

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
3
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub